About Consort Medical plc (LON:CSRT)
Consort Medical PLC is a contract development and manufacturing organization (CDMO). The Company's principal activities include designing, development and manufacture of medical drug delivery devices and services for the pharmaceutical industry. The Company operates through two segments: Bespak and Aesica. Bespak's core business is the manufacture of inhaled drug delivery devices for life sciences partners and its operations are based in the United Kingdom. The Aesica business manufactures and sells active pharmaceutical ingredients (API), formulated pharmaceutical products and packaging services to the pharmaceutical industry and its operations are based in the United Kingdom and Europe. It offers its services to customers, such as pharmaceutical companies and life sciences. Its device products include metered dose inhalers, dry powder devices, actuators, dose counters, disposable auto-injectors, nasal devices and point-of-care diagnostics devices.
Industry, Sector and Symbol:
- Sector: Healthcare
- Industry: Medical Equipment, Supplies & Distribution
- Sub-Industry: N/A
- Symbol: LON:CSRT
- CUSIP: N/A
- Web: www.consortmedical.com
Capitalization:- Market Cap: £537.55 million
- Outstanding Shares: 48,913,000
Average Prices:- 50 Day Moving Avg: GBX 1,088.19
- 200 Day Moving Avg: GBX 1,056.66
- 52 Week Range: GBX 960 - GBX 1,180
P/E:- Trailing P/E Ratio: 24.20
- P/E Growth: 0.00
Sales & Book Value:- Annual Revenue: £294 million
- Price / Sales: 1.83
- Book Value: GBX 4.34 per share
- Price / Book: 2.53
Profitability:- EBITDA: £50.8 million
- Net Margins: 8.57%
- Return on Equity: 12.04%
- Return on Assets: 5.50%
Misc:- Average Volume: 32,106 shs.
Frequently Asked Questions for Consort Medical plc (LON:CSRT)
What is Consort Medical plc's stock symbol?
Consort Medical plc trades on the London Stock Exchange (LON) under the ticker symbol "CSRT."
How often does Consort Medical plc pay dividends? What is the dividend yield for Consort Medical plc?
Consort Medical plc announced a dividend on Thursday, June 15th. Investors of record on Thursday, September 21st will be paid a dividend of GBX 13.21 per share on Friday, October 27th. This represents a yield of 1.3%. The ex-dividend date of this dividend is Thursday, September 21st. This is a positive change from Consort Medical plc's previous dividend of $7.09. The official announcement can be accessed at this link. View Consort Medical plc's Dividend History.
Where is Consort Medical plc's stock going? Where will Consort Medical plc's stock price be in 2017?
7 equities research analysts have issued 1 year price targets for Consort Medical plc's stock. Their forecasts range from GBX 1,084 to GBX 1,300. On average, they anticipate Consort Medical plc's share price to reach GBX 1,153.17 in the next twelve months. View Analyst Ratings for Consort Medical plc.
Who are some of Consort Medical plc's key competitors?
Some companies that are related to Consort Medical plc include Cardiovascular Systems (CSII), Orthofix International N.V. (OFIX), K2M Group Holdings (KTWO), Intersect ENT (XENT), AtriCure (ATRC), CryoLife (CRY), Landauer (LDR), Meridian Bioscience (VIVO), Transenterix (TRXC), Transenterix (TRXC), STAAR Surgical Company (STAA), Invacare Corporation (IVC), Exactech (EXAC), Antares Pharma (ATRS), Sientra (SIEN), Utah Medical Products (UTMD), Ocular Therapeutix (OCUL) and T2 Biosystems (TTOO).
Who are Consort Medical plc's key executives?
Consort Medical plc's management team includes the folowing people:
- Jonathan M. Glenn, Chief Executive, Executive Director
- Paul Hayes, Chief Financial Officer, Executive Director
- John W. Ilett, Group General Counsel, Company Secretary
- Keyvan Djamarani, Managing Director, Bespak
- Ian Muir, Managing Director, Aesica
- Peter J. Fellner, Non-Executive Independent Chairman of the Board
- Steve Crummett, Non-Executive Director
- Maria Charlotta Ginman-Jones, Non-Executive Director
- Andrew Joseph Hosty, Non-Executive Director
- Ian J. Nicholson, Non-Executive Director
How do I buy Consort Medical plc stock?
Shares of Consort Medical plc and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
What is Consort Medical plc's stock price today?
One share of Consort Medical plc stock can currently be purchased for approximately GBX 1,099.
MarketBeat Community Rating for Consort Medical plc (LON CSRT)MarketBeat's community ratings are surveys of what our community members think about Consort Medical plc and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Consensus Ratings for Consort Medical plc (LON:CSRT) (How are Consensus Ratings Calculated?) MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
| Ratings Breakdown: | 2 Hold Ratings, 5 Buy Ratings |
| Consensus Rating: | Buy (Score: 2.71) |
| Consensus Price Target: | GBX 1,153.17 |
Consensus Price Target History for Consort Medical plc (LON:CSRT)
Analysts' Ratings History for Consort Medical plc (LON:CSRT)
Show:
| Date | Firm | Action | Rating | Price Target | Details |
|---|
| 6/15/2017 | Numis Securities Ltd | Reiterated Rating | Hold | GBX 1,084 |  |
| 6/15/2017 | Panmure Gordon | Reiterated Rating | Buy | GBX 1,145 | |
| 6/15/2017 | Stifel Nicolaus | Reiterated Rating | Hold | GBX 1,100 | |
| 6/15/2017 | Investec | Reiterated Rating | Buy | GBX 1,165 | |
| 6/15/2017 | N+1 Singer | Reiterated Rating | Buy | GBX 1,125 | |
| 6/15/2017 | Shore Capital | Reiterated Rating | Buy | | |
| 1/23/2017 | Canaccord Genuity | Reiterated Rating | Buy | GBX 1,300 | |
| 4/4/2016 | Royal Bank Of Canada | Initiated Coverage | Sector Performer | GBX 1,150 | |
(Data available from 10/18/2015 forward)
Earnings History for Consort Medical plc (LON:CSRT)
No earnings announcements for this company have been tracked by MarketBeat.com
Earnings Estimates for Consort Medical plc (LON:CSRT)Current Year EPS Consensus Estimate: $58.03 EPS
Dividend History by Quarter for Consort Medical plc (LON CSRT)| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
| 6/15/2017 | | GBX 13.21 | 1.3% | 9/21/2017 | 9/21/2017 | 10/27/2017 |
| 12/6/2016 | | GBX 7.09 | 0.69% | 1/19/2017 | 1/19/2017 | 2/17/2017 |
| 6/16/2016 | | GBX 12.56 | 1.33% | 9/22/2016 | 9/22/2016 | 10/21/2016 |
| 12/3/2015 | | GBX 6.75 | 0.64% | 1/14/2016 | 1/14/2016 | 2/12/2016 |
| 6/16/2015 | | GBX 11.68 | 1.23% | 9/24/2015 | 9/24/2015 | 10/23/2015 |
| 12/4/2014 | | GBX 6.43 | 0.83% | 1/15/2015 | 1/15/2015 | 2/13/2015 |
| 6/17/2014 | | GBX 13.35 | 1.53% | 9/17/2014 | 9/17/2014 | 10/24/2014 |
| 12/4/2013 | | GBX 7.35 | 0.82% | 1/15/2014 | 1/15/2014 | 2/14/2014 |
(Data available from 1/1/2013 forward)
Insider Trading and Institutional Ownership History for Consort Medical plc (LON:CSRT)Insider Trades by Quarter for Consort Medical plc (LON:CSRT)| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Details |
|---|
| 10/9/2017 | Paul Hayes | Insider | Buy | 14 | GBX 1,088 | £152.32 | |
| 9/7/2017 | Paul Hayes | Insider | Buy | 14 | GBX 1,088 | £152.32 | |
| 8/7/2017 | Paul Hayes | Insider | Buy | 13 | GBX 1,100 | £143 | |
| 7/7/2017 | Jonathan Glenn | Insider | Buy | 15 | GBX 1,029 | £154.35 | |
| 6/20/2017 | Paul Hayes | Insider | Buy | 4,000 | GBX 1,094 | £43,760 | |
| 11/7/2016 | Richard Cotton | Insider | Buy | 13 | GBX 1,153 | £149.89 | |
| 10/7/2016 | Richard Cotton | Insider | Buy | 14 | GBX 1,098 | £153.72 | |
| 9/7/2016 | Cotton,Richard | Insider | Buy | 14 | GBX 1,051 | £147.14 | |
| 9/5/2016 | Cotton,Richard | Insider | Buy | 1,382 | GBX 651 | £8,996.82 | |
| 6/22/2016 | Cotton,Richard | Insider | Sell | 55,153 | GBX 992 | £547,117.76 | |
| 3/15/2016 | Ginman-Jones,Charlotta | Insider | Buy | 948 | GBX 1,048 | £9,935.04 | |
| 9/15/2015 | Glenn,Jonathan | Insider | Sell | 3,234 | GBX 960 | £31,046.40 | |
| 7/30/2015 | Crummett,Steve | Insider | Buy | 1,000 | GBX 929 | £9,290 | |
| 7/1/2015 | Cotton,Richard | Insider | Sell | 24,146 | GBX 9.13 | £2,204.53 | |
| 1/6/2015 | Jonathan Glenn | Insider | Sell | 67,000 | GBX 845 | £566,150 | |
(Data available from 1/1/2013 forward)
Headline Trends for Consort Medical plc (LON:CSRT)
Latest Headlines for Consort Medical plc (LON:CSRT)
| Source: |
|
Consort Medical plc (CSRT) Chart for Wednesday, October, 18, 2017
